The Centre quarterly newsletter, March 2026 issue, is now available.
In this issue:
Main event…
Chemokine for the therapeutic treatment of medulloblastoma
managed by Consiglio Nazionale delle Ricerche
TRL: 5
Availability: Licensing
Status: EP Patent